QingYan formula extracts protect against postmenopausal osteoporosis in ovariectomized rat model via active ER-dependent MEK/ERK and PI3K/Akt signal pathways
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 268, 113644
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81573632, 81774203)
This publication has 27 references indexed in Scilit:
- Salvia miltiorrhiza bunge increases estrogen level without side effects on reproductive tissues in immature/ovariectomized miceAging, 2016
- The relationship between breast density and bone mineral density in never users of postmenopausal hormone therapyAging Clinical and Experimental Research, 2016
- Effect of the Interaction of Veratrum Nigrum with Panax Ginseng on Estrogenic Activity In Vivo and In VitroScientific Reports, 2016
- Treatment with QiBaoMeiRan, a Chinese herbal formula, prevents bone loss in ovariectomized ratClimacteric, 2015
- HIF-1α disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expressionIn Vitro Cellular & Developmental Biology - Animal, 2015
- The osteoclast, bone remodelling and treatment of metabolic bone diseaseEuropean Journal of Clinical Investigation, 2012
- In search of an osteoblast cell model for in vitro research2012
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal OsteoporosisEndocrine Practice, 2010
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Advances in the osteoblast lineageBiochemistry and Cell Biology, 1998